vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Honest Company, Inc. (HNST). Click either name above to swap in a different company.
Honest Company, Inc. is the larger business by last-quarter revenue ($88.0M vs $44.9M, roughly 2.0× AbCellera Biologics Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -26.8%, a 6.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -11.8%). Honest Company, Inc. produced more free cash flow last quarter ($18.1M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 1.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
The Honest Company, Inc. is an American digital-first consumer goods company, based in Los Angeles and founded by actress Jessica Alba, Christopher Gavigan, and Brian Lee. The company had $319 million in 2021 sales, and was valued at roughly $550 million as of February 2022. Carla Vernón, Chief Executive Officer, is one of the first Afro-Latina CEOs of a U.S. publicly traded company. The Honest Company has raised multiple rounds of venture capital, and went public via an initial public offeri...
ABCL vs HNST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $88.0M |
| Net Profit | $-8.9M | $-23.6M |
| Gross Margin | — | 15.7% |
| Operating Margin | -63.7% | -27.5% |
| Net Margin | -19.9% | -26.8% |
| Revenue YoY | 788.4% | -11.8% |
| Net Profit YoY | 73.9% | -2813.2% |
| EPS (diluted) | $-0.03 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $88.0M | ||
| Q3 25 | $9.0M | $92.6M | ||
| Q2 25 | $17.1M | $93.5M | ||
| Q1 25 | $4.2M | $97.3M | ||
| Q4 24 | $5.0M | $99.8M | ||
| Q3 24 | $6.5M | $99.2M | ||
| Q2 24 | $7.3M | $93.0M | ||
| Q1 24 | $10.0M | $86.2M |
| Q4 25 | $-8.9M | $-23.6M | ||
| Q3 25 | $-57.1M | $758.0K | ||
| Q2 25 | $-34.7M | $3.9M | ||
| Q1 25 | $-45.6M | $3.3M | ||
| Q4 24 | — | $-809.0K | ||
| Q3 24 | $-51.1M | $165.0K | ||
| Q2 24 | $-36.9M | $-4.1M | ||
| Q1 24 | $-40.6M | $-1.4M |
| Q4 25 | — | 15.7% | ||
| Q3 25 | — | 37.3% | ||
| Q2 25 | — | 40.4% | ||
| Q1 25 | — | 38.7% | ||
| Q4 24 | — | 38.8% | ||
| Q3 24 | — | 38.7% | ||
| Q2 24 | — | 38.3% | ||
| Q1 24 | — | 37.0% |
| Q4 25 | -63.7% | -27.5% | ||
| Q3 25 | -851.8% | 0.3% | ||
| Q2 25 | -290.2% | 3.1% | ||
| Q1 25 | -1479.6% | 2.6% | ||
| Q4 24 | — | -1.0% | ||
| Q3 24 | -1439.4% | 0.1% | ||
| Q2 24 | -1276.2% | -4.3% | ||
| Q1 24 | -551.5% | -1.5% |
| Q4 25 | -19.9% | -26.8% | ||
| Q3 25 | -637.8% | 0.8% | ||
| Q2 25 | -203.3% | 4.1% | ||
| Q1 25 | -1077.2% | 3.3% | ||
| Q4 24 | — | -0.8% | ||
| Q3 24 | -785.4% | 0.2% | ||
| Q2 24 | -504.3% | -4.4% | ||
| Q1 24 | -408.0% | -1.6% |
| Q4 25 | $-0.03 | $-0.21 | ||
| Q3 25 | $-0.19 | $0.01 | ||
| Q2 25 | $-0.12 | $0.03 | ||
| Q1 25 | $-0.15 | $0.03 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | $-0.17 | $0.00 | ||
| Q2 24 | $-0.13 | $-0.04 | ||
| Q1 24 | $-0.14 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $89.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $169.7M |
| Total Assets | $1.4B | $225.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $89.6M | ||
| Q3 25 | $83.2M | $71.5M | ||
| Q2 25 | $92.4M | $72.1M | ||
| Q1 25 | $159.3M | $72.8M | ||
| Q4 24 | $156.3M | $75.4M | ||
| Q3 24 | $126.6M | $53.4M | ||
| Q2 24 | $148.3M | $36.6M | ||
| Q1 24 | $123.6M | $33.6M |
| Q4 25 | $966.9M | $169.7M | ||
| Q3 25 | $964.0M | $190.2M | ||
| Q2 25 | $1.0B | $187.0M | ||
| Q1 25 | $1.0B | $180.4M | ||
| Q4 24 | $1.1B | $174.3M | ||
| Q3 24 | $1.1B | $133.9M | ||
| Q2 24 | $1.1B | $129.7M | ||
| Q1 24 | $1.1B | $124.8M |
| Q4 25 | $1.4B | $225.4M | ||
| Q3 25 | $1.4B | $241.5M | ||
| Q2 25 | $1.4B | $249.0M | ||
| Q1 25 | $1.3B | $265.3M | ||
| Q4 24 | $1.4B | $247.4M | ||
| Q3 24 | $1.4B | $209.2M | ||
| Q2 24 | $1.4B | $200.2M | ||
| Q1 24 | $1.5B | $198.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $19.3M |
| Free Cash FlowOCF − Capex | $-44.6M | $18.1M |
| FCF MarginFCF / Revenue | -99.4% | 20.5% |
| Capex IntensityCapex / Revenue | 21.9% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $19.3M | ||
| Q3 25 | $-52.6M | $-504.0K | ||
| Q2 25 | $-32.4M | $-745.0K | ||
| Q1 25 | $-11.6M | $-2.9M | ||
| Q4 24 | $-108.6M | $-16.8M | ||
| Q3 24 | $-28.9M | $15.1M | ||
| Q2 24 | $-30.0M | $2.9M | ||
| Q1 24 | $-41.7M | $336.0K |
| Q4 25 | $-44.6M | $18.1M | ||
| Q3 25 | $-61.5M | $-624.0K | ||
| Q2 25 | $-45.8M | $-826.0K | ||
| Q1 25 | $-22.2M | $-3.0M | ||
| Q4 24 | $-187.0M | $-17.2M | ||
| Q3 24 | $-47.4M | $15.0M | ||
| Q2 24 | $-50.1M | $2.9M | ||
| Q1 24 | $-65.8M | $260.0K |
| Q4 25 | -99.4% | 20.5% | ||
| Q3 25 | -687.0% | -0.7% | ||
| Q2 25 | -267.9% | -0.9% | ||
| Q1 25 | -524.0% | -3.1% | ||
| Q4 24 | -3702.8% | -17.2% | ||
| Q3 24 | -728.4% | 15.1% | ||
| Q2 24 | -683.8% | 3.1% | ||
| Q1 24 | -661.5% | 0.3% |
| Q4 25 | 21.9% | 1.4% | ||
| Q3 25 | 99.7% | 0.1% | ||
| Q2 25 | 78.2% | 0.1% | ||
| Q1 25 | 251.1% | 0.1% | ||
| Q4 24 | 1552.7% | 0.3% | ||
| Q3 24 | 284.6% | 0.1% | ||
| Q2 24 | 274.6% | 0.0% | ||
| Q1 24 | 242.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | — | -0.19× | ||
| Q1 25 | — | -0.90× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 91.42× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
